J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)

BOM:506943 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 2, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	269,165	252,540	255,986	152,503	121,735	96,881
Market Cap Growth	-3.94%	-1.35%	67.86%	25.27%	25.65%	146.60%
Enterprise Value	264,943	249,373	256,557	154,282	114,656	92,331
Last Close Price	1718.85	1615.90	1629.23	966.74	765.91	603.49
PE Ratio	39.83	38.29	46.32	37.21	31.59	21.63
Forward PE	32.20	31.77	35.43	29.01	24.70	23.07
PS Ratio	6.72	6.45	7.35	4.84	5.02	4.74
PB Ratio	7.84	7.36	8.76	6.15	5.69	5.34
P/TBV Ratio	13.07	12.27	17.33	13.86	8.66	5.63
P/FCF Ratio	-	31.38	37.99	27.42	113.49	36.28
P/OCF Ratio	-	27.98	31.97	24.26	71.55	30.78
PEG Ratio	1.61	1.53	1.43	1.49	1.40	0.99
EV/Sales Ratio	6.61	6.37	7.36	4.90	4.73	4.52
EV/EBITDA Ratio	25.07	24.48	29.11	21.92	21.29	16.79
EV/EBIT Ratio	30.15	29.00	34.01	26.07	24.19	18.86
EV/FCF Ratio	-	30.98	38.08	27.74	106.89	34.58
Debt / Equity Ratio	0.01	0.01	0.13	0.23	0.03	0.03
Debt / EBITDA Ratio	0.03	0.03	0.42	0.81	0.10	0.08
Debt / FCF Ratio	-	0.04	0.56	1.03	0.51	0.17
Asset Turnover	-	0.95	0.92	1.02	1.00	1.01
Inventory Turnover	-	2.63	2.60	2.85	2.29	2.32
Quick Ratio	-	2.02	1.34	1.57	1.70	3.22
Current Ratio	-	3.04	2.13	2.76	3.27	4.50
Return on Equity (ROE)	-	20.75%	20.45%	17.75%	19.54%	27.59%
Return on Assets (ROA)	-	13.00%	12.49%	12.01%	12.22%	15.08%
Return on Capital (ROIC)	16.24%	15.90%	14.84%	14.10%	14.62%	18.37%
Return on Capital Employed (ROCE)	-	23.60%	24.10%	19.70%	21.30%	25.90%
Earnings Yield	2.55%	2.61%	2.16%	2.69%	3.17%	4.62%
FCF Yield	-	3.19%	2.63%	3.65%	0.88%	2.76%
Dividend Yield	0.90%	0.96%	0.75%	0.92%	1.08%	1.37%
Payout Ratio	-	35.94%	28.41%	31.13%	33.10%	16.35%
Buyback Yield / Dilution	0.13%	-0.07%	-1.26%	-1.23%	-0.10%	2.86%
Total Shareholder Return	1.03%	0.89%	-0.51%	-0.32%	0.98%	4.23%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.